Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor) Fab Fragment (Human-Mouse Monoclonal Rhufab V2 1-Chain), Disulfide With Human-Mouse Monoclonal Rhufab V2 Light Chain
Radiation-Induced Disorder
The New York Eye Cancer Centermonoclonal_antibodyPhase 4 / ApprovedDormant
BBB
72/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 57/ 100
- Competitive Position
- 95/ 100
Competitive context
10 Active assets in the Radiation-Induced Disorder cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Losartan Massachusetts General Hospital | Phase 2 | B |
Corpril Wake Forest University Health Sciences | Phase 2 | B |
Ozurdex Arman Mashayekhi | Phase 2 | CCC |
Chlorophyllin Copper Complex Sodium Tata Memorial Centre | Phase 2 | CCC |
[68ga]cbp8 Massachusetts General Hospital | Phase 2 | CCC |
View all 13 →
Same molecule, other indications
Immunoglobulin G1, Anti-(Human Vascular Endothelial Growth Factor) Fab Fragment (Human-Mouse Monoclonal Rhufab V2 1-Chain), Disulfide With Human-Mouse Monoclonal Rhufab V2 Light Chain is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →